BR9608318A - Esteres de carbapenems - Google Patents

Esteres de carbapenems

Info

Publication number
BR9608318A
BR9608318A BR9608318A BR9608318A BR9608318A BR 9608318 A BR9608318 A BR 9608318A BR 9608318 A BR9608318 A BR 9608318A BR 9608318 A BR9608318 A BR 9608318A BR 9608318 A BR9608318 A BR 9608318A
Authority
BR
Brazil
Prior art keywords
carbapenem
esters
carbapenem esters
Prior art date
Application number
BR9608318A
Other languages
English (en)
Inventor
Stephen Christopher Marti Fell
Alfred John Eglington
Stephen Frederick Moss
George Burton
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508960.3A external-priority patent/GB9508960D0/en
Priority claimed from GBGB9508959.5A external-priority patent/GB9508959D0/en
Priority claimed from GBGB9508964.5A external-priority patent/GB9508964D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9608318A publication Critical patent/BR9608318A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BR9608318A 1995-05-03 1996-05-02 Esteres de carbapenems BR9608318A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9508960.3A GB9508960D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508959.5A GB9508959D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508964.5A GB9508964D0 (en) 1995-05-03 1995-05-03 Novel compounds
PCT/EP1996/001882 WO1996034869A1 (en) 1995-05-03 1996-05-02 Esters of carbapenems

Publications (1)

Publication Number Publication Date
BR9608318A true BR9608318A (pt) 1999-01-26

Family

ID=27267697

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608318A BR9608318A (pt) 1995-05-03 1996-05-02 Esteres de carbapenems

Country Status (14)

Country Link
EP (1) EP0823911A1 (pt)
JP (1) JPH11504912A (pt)
KR (1) KR19990008354A (pt)
CN (1) CN1184480A (pt)
AU (1) AU5814196A (pt)
BR (1) BR9608318A (pt)
CA (1) CA2217885A1 (pt)
CZ (1) CZ347697A3 (pt)
HU (1) HUP9801061A3 (pt)
MX (1) MX9708422A (pt)
NO (1) NO974995L (pt)
PL (1) PL323148A1 (pt)
TR (1) TR199701289T2 (pt)
WO (1) WO1996034869A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100771019B1 (ko) * 2002-03-20 2007-10-29 주식회사 만도 브레이크 액압제어장치
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK637888A (da) * 1987-11-24 1989-05-25 Hoffmann La Roche Carboxylsyreestere
GB8809534D0 (en) * 1988-04-22 1988-05-25 Beecham Group Plc Novel compounds
SK53696A3 (en) * 1993-10-29 1996-10-02 Smithkline Beecham Plc Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
CZ347697A3 (cs) 1998-06-17
CN1184480A (zh) 1998-06-10
MX9708422A (es) 1998-02-28
TR199701289T2 (xx) 1998-08-21
AU5814196A (en) 1996-11-21
JPH11504912A (ja) 1999-05-11
NO974995D0 (no) 1997-10-30
KR19990008354A (ko) 1999-01-25
HUP9801061A2 (hu) 1998-08-28
HUP9801061A3 (en) 1999-01-28
PL323148A1 (en) 1998-03-16
EP0823911A1 (en) 1998-02-18
CA2217885A1 (en) 1996-11-07
WO1996034869A1 (en) 1996-11-07
NO974995L (no) 1997-10-30

Similar Documents

Publication Publication Date Title
DE69610809T2 (de) Hybrides Antriebssystem
FI952844A (fi) Menetelmä kanavanvaihdon parantamiseksi
DE69608943T2 (de) Schwenkender Getriebedämpfer
BR9609682A (pt) Foto-desinfetantes de baixa nuança
BR9612325A (pt) Combinações microbianas óticas
FI941215A0 (fi) Uudet 2-tiosubstituoidut karbapeneemit
BR9611062A (pt) Antibioticos de cefalosporina
NO975151L (no) Antibakterielle cefalosporiner
KR970702865A (ko) 신규 카르바페넴 유도체(Novel Carbapenem Derivatives)
DE59601330D1 (de) Lenkgetriebe
BR9610022A (pt) Esteres
BR9608318A (pt) Esteres de carbapenems
KR970024376U (ko) 방진구
FR2741778B1 (fr) Mouleuse-doseuse de melange caille-serum
AU1730197A (en) Optical pulse source
BR9611627A (pt) Carboxilesterase de malathion
PT839024E (pt) Formulacoes de monensina
AU7290096A (en) Substituted benzylidenecyanoacetic esters
NO974994D0 (no) Estere av karbapenemer
DE69622816T2 (de) Polyolefinfolie
DK0811279T3 (da) Dæmpningsfri optisk forbindelse
KR960037287U (ko) 유리상자
KR970028406U (ko) 착탈식 견인장치
DE9416629U1 (de) Variables Displaysystem
FI951713A0 (fi) Foerfarande foer toemning av en mapp

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law